Theravance Biopharma Inc. (TBPH)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

9.88

0.10%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	57.42M	51.35M	55.31M	71.86M	73.41M	60.37M	15.39M	48.65M	42.13M	11.69M	226.00K	130.15M
Cost of Revenue	40.62M	6.59M	7.29M	260.95M	219.25M	715.00K	6.03M	2.89M	4.66M	4.06M	120.58M	114.00M
Gross Profit	16.80M	44.76M	48.02M	-189.10M	-145.83M	59.66M	9.36M	45.75M	37.47M	7.63M	-120.35M	16.15M
Operating Income	-53.29M	-91.96M	-257.78M	-297.76M	-251.91M	-238.75M	-260.12M	-180.47M	-181.90M	-232.54M	-156.28M	-9.57M
Interest Income	9.12M	8.54M	1.11M	2.83M	8.39M	11.97M	4.96M	1.31M	631.00K	1.86M	-	-
Pretax Income	-49.27M	-92.81M	-199.58M	-286.54M	-241.68M	-226.09M	-271.71M	-180.56M	-181.27M	-230.67M	-156.28M	-9.57M
Net Income	-55.19M	-92.82M	-199.43M	-278.02M	-236.46M	-215.52M	-285.40M	-190.67M	-182.22M	-237.04M	-156.28M	-9.57M
Selling & General & Admin	70.09M	67.07M	99.30M	108.66M	106.08M	97.06M	95.59M	84.51M	90.20M	71.65M	35.93M	25.73M
Research & Development	40.62M	63.39M	193.66M	260.95M	219.25M	201.35M	173.89M	141.71M	129.16M	168.52M	120.58M	114.00M
Other Expenses	-	-	-	-1.61M	-	-	-	-	-	-	-	-
Operating Expenses	110.72M	130.47M	292.95M	369.61M	325.33M	298.41M	269.48M	226.22M	219.37M	240.17M	156.51M	139.72M
Interest Expense	2.35M	6.37M	46.89M	44.59M	31.86M	10.48M	8.55M	1.40M	-	-	-	-
Selling & Marketing Expenses	5.10M	8.00M	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	110.72M	130.47M	292.95M	369.61M	325.33M	299.12M	275.51M	229.12M	224.03M	244.23M	156.51M	139.72M
Income Tax	5.92M	9.00K	-151.00K	-8.52M	-5.22M	-10.56M	13.69M	10.11M	951.00K	6.36M	-	-
Shares Outstanding (Basic)	55.30M	73.59M	69.46M	62.34M	55.61M	53.97M	52.35M	44.71M	34.15M	31.75M	31.74M	31.74M
Shares Outstanding (Diluted)	55.30M	73.59M	69.46M	62.34M	55.61M	53.97M	52.35M	44.71M	34.15M	31.75M	32.26M	32.26M
EPS (Basic)	-1	-1.26	-2.87	-4.46	-4.25	-3.99	-5.45	-4.26	-5.34	-7.46	-4.92	-0.3
EPS (Diluted)	-1	-1.26	-2.87	-4.46	-4.25	-3.99	-5.45	-4.26	-5.34	-7.46	-4.84	-0.3
EBITDA	-40.87M	-79.86M	-249.39M	-294.00M	-203.29M	-212.44M	-259.14M	-176.04M	-178.77M	-228.01M	-153.63M	-6.32M
Depreciation & Amortization	6.05M	6.59M	7.29M	6.64M	6.52M	3.17M	4.03M	3.12M	2.99M	2.66M	2.65M	3.25M